Cancer Health Treatment Update Armored CAR-T Therapy Shows Promise for Liver Cancer In its first human trial, C-CAR031 shrank liver tumors in six out of the eight patients who received the highest dose. Cancer Health Summer 2024 Check out our latest print edition! FDA Approves Two First-Line Immunotherapies for Endometrial Cancer Immune checkpoint inhibitors Keytruda and Imfinzi delayed disease progression in Phase III trials. Doctor Is Cancer-Free Following World-First Treatment He Developed Australian of the Year Richard Scolyer treated his brain cancer using an experimental immunotherapy he and his team developed. Obesity at Time of Cancer Diagnosis Brings Higher Risk for Second Cancer Compared to cancer survivors with BMI in the normal range, those with obesity were 34% more likely to develop any second cancer. News From ASCO 2024 See all our reports from the world's biggest cancer conference. Advertisement News About COVID-19 See all our coverage of COVID-19, including how it affects people living with cancer. For more news about SARS-CoV-2, visit our sister site, COVIDHealth.com. Newsfeed Robert Gallo, Codiscoverer of HIV, Takes His Research to Tampa New Way to Reduce Anxiety and Improve Quality of Life after Stem Cell Transplant Doctor Is Cancer-Free Following World-First Treatment He Developed Infectious H5N1 Influenza Virus in Raw Milk Rapidly Declines With Heat Treatment Blog: National Cancer Institute Progress Against Anal Cancer Opens Door to Screening and Prevention Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses Inviting Innovation in Cancer Clinical Trials Ojemda Approved for Some Children With Brain Tumors Newsfeed Robert Gallo, Codiscoverer of HIV, Takes His Research to Tampa New Way to Reduce Anxiety and Improve Quality of Life after Stem Cell Transplant Doctor Is Cancer-Free Following World-First Treatment He Developed Infectious H5N1 Influenza Virus in Raw Milk Rapidly Declines With Heat Treatment Blog: National Cancer Institute Progress Against Anal Cancer Opens Door to Screening and Prevention Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses Inviting Innovation in Cancer Clinical Trials Ojemda Approved for Some Children With Brain Tumors

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: